open access
Predictors of left atrial fibrosis in patients with atrial fibrillation referred for catheter ablation
, 1, 1, 1, 1, 1, 1, 12, 1, 1
Affiliations- Department of Cardiology, University Heart Center, University Hospital Zurich, Switzerland
- Center for Integrative Human Physiology, University of Zurich, Switzerland
open access
Abstract
Background: Left atrial (LA) fibrosis in patients with atrial fibrillation (AF) is associated with an increased risk of AF recurrence after catheter ablation. Therefore, we searched for clinical risk factors that confer an increased risk of LA fibrosis, which can influence the treatment strategy.
Methods: We included 94 patients undergoing 3-dimensional electroanatomical voltage mapping-guided catheter ablation of AF. LA low-voltage areas during sinus rhythm as a surrogate parameter of fibrosis were measured with the CARTO3 mapping system and adjusted for LA volumes obtained by computed tomography. Blood tests including N-terminal prohormone of B-type natriuretic peptide (NT-proBNP) and echocardiographic parameters of left ventricular function were also analyzed.
Results: Patients were 62.5 ± 11.4 years old, and 29% were female. LA fibrosis was present in 65%, with 50% having a fibrotic area > 5% (≥ Utah-Stage 1). Mean left ventricular ejection fraction (LVEF) was 53.9 ± 10.5%. Patients with LA fibrosis had higher NT-proBNP levels (869 ± 1056 vs. 552 ± 859 ng/L, p = 0.001) and larger LA volumes (body surface area-corrected 63.3 ± 19.3 vs. 80 ± 27.1 mL/m2, p = 0.003). In univariable analyses, LA fibrosis was significantly associated with female gender, older age, increased LA volumes, hypertension, statin therapy, higher NT-proBNP values, and echocardiographic E/e’. In bivariable analyses, higher NT-proBNP, echocardiographic parameters of diastolic dysfunction, female gender, older age, and higher DR-FLASH scores remained as independent predictors of LA fibrosis.
Conclusions: In this single-center longitudinal study, surrogate parameters of elevated left-sided cardiac filling pressures such as higher NT-proBNP levels and higher echocardiographic E/e’ values as well as female gender independently predicted the prevalence of LA fibrosis in patients referred for catheter ablation of AF.
Abstract
Background: Left atrial (LA) fibrosis in patients with atrial fibrillation (AF) is associated with an increased risk of AF recurrence after catheter ablation. Therefore, we searched for clinical risk factors that confer an increased risk of LA fibrosis, which can influence the treatment strategy.
Methods: We included 94 patients undergoing 3-dimensional electroanatomical voltage mapping-guided catheter ablation of AF. LA low-voltage areas during sinus rhythm as a surrogate parameter of fibrosis were measured with the CARTO3 mapping system and adjusted for LA volumes obtained by computed tomography. Blood tests including N-terminal prohormone of B-type natriuretic peptide (NT-proBNP) and echocardiographic parameters of left ventricular function were also analyzed.
Results: Patients were 62.5 ± 11.4 years old, and 29% were female. LA fibrosis was present in 65%, with 50% having a fibrotic area > 5% (≥ Utah-Stage 1). Mean left ventricular ejection fraction (LVEF) was 53.9 ± 10.5%. Patients with LA fibrosis had higher NT-proBNP levels (869 ± 1056 vs. 552 ± 859 ng/L, p = 0.001) and larger LA volumes (body surface area-corrected 63.3 ± 19.3 vs. 80 ± 27.1 mL/m2, p = 0.003). In univariable analyses, LA fibrosis was significantly associated with female gender, older age, increased LA volumes, hypertension, statin therapy, higher NT-proBNP values, and echocardiographic E/e’. In bivariable analyses, higher NT-proBNP, echocardiographic parameters of diastolic dysfunction, female gender, older age, and higher DR-FLASH scores remained as independent predictors of LA fibrosis.
Conclusions: In this single-center longitudinal study, surrogate parameters of elevated left-sided cardiac filling pressures such as higher NT-proBNP levels and higher echocardiographic E/e’ values as well as female gender independently predicted the prevalence of LA fibrosis in patients referred for catheter ablation of AF.
Keywords
atrial fibrillation, heart failure with preserved ejection fraction, diastolic dysfunction, gender medicine, atrial fibrosis
Supp./Additional Files (1)
About this articleTitle
Predictors of left atrial fibrosis in patients with atrial fibrillation referred for catheter ablation
Journal
Issue
Article type
Original Article
Pages
413-422
Published online
2022-03-04
Page views
4785
Article views/downloads
782
DOI
Pubmed
Bibliographic record
Cardiol J 2022;29(3):413-422.
Keywords
atrial fibrillation
heart failure with preserved ejection fraction
diastolic dysfunction
gender medicine
atrial fibrosis
Authors
Valentina A. Rossi
Iva Krizanovic-Grgic
Jan Steffel
Daniel Hofer
Thomas Wolber
Corinna B. Brunckhorst
Frank Ruschitzka
Firat Duru
Alexander Breitenstein
Ardan M. Saguner
References (35)- Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016; 37(38): 2893–2962.
- Daccarett M, Badger TJ, Akoum N, et al. Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation. J Am Coll Cardiol. 2011; 57(7): 831–838.
- Seewöster T, Kosich F, Sommer P, et al. Prediction of low-voltage areas using modified APPLE score. Europace. 2021; 23(4): 575–580.
- Asvestas D, Vlachos K, Bazoukis G, et al. Left atrial voltage mapping using a new impedance-based algorithm in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 2018; 41(11): 1447–1453.
- Huo Y, Gaspar T, Pohl M, et al. Prevalence and predictors of low voltage zones in the left atrium in patients with atrial fibrillation. Europace. 2018; 20(6): 956–962.
- Akoum N, Mahnkopf C, Kholmovski EG, et al. Age and sex differences in atrial fibrosis among patients with atrial fibrillation. Europace. 2018; 20(7): 1086–1092.
- Kornej J, Schumacher K, Dinov B, et al. Prediction of electro-anatomical substrate and arrhythmia recurrences using APPLE, DR-FLASH and MB-LATER scores in patients with atrial fibrillation undergoing catheter ablation. Sci Rep. 2018; 8(1): 12686.
- Rolf S, Kircher S, Arya A, et al. Tailored atrial substrate modification based on low-voltage areas in catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol. 2014; 7(5): 825–833.
- Kosiuk J, Dinov B, Kornej J, et al. Prospective, multicenter validation of a clinical risk score for left atrial arrhythmogenic substrate based on voltage analysis: DR-FLASH score. Heart Rhythm. 2015; 12(11): 2207–2212.
- Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016; 17(12): 1321–1360.
- Stegmann C, Jahnke C, Paetsch I, et al. Association of left ventricular late gadolinium enhancement with left atrial low voltage areas in patients with atrial fibrillation. Europace. 2018; 20(10): 1606–1611.
- Saguner AM, Maurer T, Wissner E, et al. Catheter ablation of atrial fibrillation in very young adults: a 5-year follow-up study. Europace. 2018; 20(1): 58–64.
- Verma A, Wazni OM, Marrouche NF, et al. Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: an independent predictor of procedural failure. J Am Coll Cardiol. 2005; 45(2): 285–292.
- Akdis D, Saguner AM, Shah K, et al. Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy/dysplasia: from a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome. Eur Heart J. 2017; 38(19): 1498–1508.
- Marrouche NF, Wilber D, Hindricks G, et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA. 2014; 311(5): 498–506.
- Platonov PG, Mitrofanova LB, Orshanskaya V, et al. Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. J Am Coll Cardiol. 2011; 58(21): 2225–2232.
- Spach MS, Boineau JP. Microfibrosis produces electrical load variations due to loss of side-to-side cell connections: a major mechanism of structural heart disease arrhythmias. Pacing Clin Electrophysiol. 1997; 20(2 Pt 2): 397–413.
- Kottkamp H. Human atrial fibrillation substrate: towards a specific fibrotic atrial cardiomyopathy. Eur Heart J. 2013; 34(35): 2731–2738.
- Siebermair J, Kholmovski EG, Marrouche N. Assessment of left atrial fibrosis by late gadolinium enhancement magnetic resonance imaging: methodology and clinical implications. JACC Clin Electrophysiol. 2017; 3(8): 791–802.
- Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016; 37(27): 2129–2200.
- Neilan TG, Mongeon FP, Shah RV, et al. Myocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation. JACC Cardiovasc Imaging. 2014; 7(1): 1–11.
- Hussein AA, Saliba WI, Martin DO, et al. Plasma B-type natriuretic peptide levels and recurrent arrhythmia after successful ablation of lone atrial fibrillation. Circulation. 2011; 123(19): 2077–2082.
- Sartipy U, Dahlström U, Fu M, et al. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction. JACC Heart Fail. 2017; 5(8): 565–574.
- Kornej J, Büttner P, Sommer P, et al. Prediction of electro-anatomical substrate using APPLE score and biomarkers. Europace. 2019; 21(1): 54–59.
- Wu XY, Li SN, Wen SN, et al. Plasma galectin-3 predicts clinical outcomes after catheter ablation in persistent atrial fibrillation patients without structural heart disease. Europace. 2015; 17(10): 1541–1547.
- Begg GA, Karim R, Oesterlein T, et al. Intra-cardiac and peripheral levels of biochemical markers of fibrosis in patients undergoing catheter ablation for atrial fibrillation. Europace. 2017; 19(12): 1944–1950.
- Takemoto Y, Ramirez RJ, Yokokawa M, et al. Galectin-3 regulates atrial fibrillation remodeling and predicts catheter ablation outcomes. JACC Basic Transl Sci. 2016; 1(3): 143–154.
- Clementy N, Garcia B, André C, et al. Galectin-3 level predicts response to ablation and outcomes in patients with persistent atrial fibrillation and systolic heart failure. PLoS One. 2018; 13(8): e0201517.
- Kornej J, Hindricks G, Shoemaker MB, et al. The APPLE score: a novel and simple score for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation. Clin Res Cardiol. 2015; 104(10): 871–876.
- Ballesteros G, Ravassa S, Bragard J, et al. Association of left atrium voltage amplitude and distribution with the risk of atrial fibrillation recurrence and evolution after pulmonary vein isolation: An ultrahigh-density mapping study. J Cardiovasc Electrophysiol. 2019; 30(8): 1231–1240.
- Ammar-Busch S, Buiatti A, Tatzber A, et al. Predictors of low voltage areas in persistent atrial fibrillation: is it really a matter of time? J Interv Card Electrophysiol. 2020; 57(3): 345–352.
- Kiedrowicz RM, Wielusinski M, Wojtarowicz A, et al. Predictors of the voltage derived left atrial fibrosis in patients with long-standing persistent atrial fibrillation. Cardiol J. 2020 [Epub ahead of print].
- Kaufman ES, Zimmermann PA, Wang T, et al. Risk of proarrhythmic events in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: a multivariate analysis. J Am Coll Cardiol. 2004; 44(6): 1276–1282.
- Maeda S, Yamauchi Y, Tao S, et al. Small reentrant atrial tachycardia adjacent to left aortic sinus of valsalva. Circ J. 2013; 77(12): 3054–3055.
- Hori Y, Nakahara S, Kamijima T, et al. Influence of left atrium anatomical contact area in persistent atrial fibrillation-relationship between low-voltage area and fractionated electrogram. Circ J. 2014; 78(8): 1851–1857.
